ArticleInternational journal of molecular sciences2026

TLR4: A Potential Therapeutic Target in the Experimental Pathogenesis of Hemolytic-Uremic Syndrome.

Elisa Varrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.